Workflow
MP0712 (DLL3 targeting radiotherapeutic)
icon
Search documents
Molecular Partners (NasdaqGS:MOLN) Update / briefing Transcript
2026-02-02 14:02
Molecular Partners (NasdaqGS:MOLN) Update / briefing February 02, 2026 08:00 AM ET Company ParticipantsKen Herrmann - Chairman of the Scientific Advisory BoardMichael Stumpp - EVP of ProjectsPatrick Amstutz - CEOPhilippe Legenne - CMOSeth Lewis - Head of Investor Relations and StrategyConference Call ParticipantsAlbert Agustinus - AnalystBill Maughan - AnalystCharles Zhu - AnalystChiara Montironi - AnalystGeorg Zimmermann - AnalystMichael Nedelcovych - Senior Equity AnalystOperatorGood day, and welcome to t ...